.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Teva
Accenture
Cipla
Harvard Business School
Boehringer Ingelheim
QuintilesIMS
US Army
US Department of Justice
Chubb

Generated: July 22, 2017

DrugPatentWatch Database Preview

Rotigotine - Generic Drug Details

« Back to Dashboard

What are the generic sources for rotigotine and what is the scope of rotigotine patent protection?

Rotigotine
is the generic ingredient in one branded drug marketed by Ucb Inc and is included in one NDA. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Rotigotine has one hundred and sixteen patent family members in thirty-two countries.

There are six drug master file entries for rotigotine. One supplier is listed for this compound.

Summary for Generic Name: rotigotine

Tradenames:1
Patents:6
Applicants:1
NDAs:1
Drug Master File Entries: see list6
Suppliers / Packagers: see list1
Bulk Api Vendors: see list43
Clinical Trials: see list70
Patent Applications: see list143
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:rotigotine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc
NEUPRO
rotigotine
FILM, EXTENDED RELEASE;TRANSDERMAL021829-001May 9, 2007RXYesYes8,246,980► SubscribeY ► Subscribe
Ucb Inc
NEUPRO
rotigotine
FILM, EXTENDED RELEASE;TRANSDERMAL021829-002May 9, 2007RXYesNo8,246,979► SubscribeY ► Subscribe
Ucb Inc
NEUPRO
rotigotine
FILM, EXTENDED RELEASE;TRANSDERMAL021829-002May 9, 2007RXYesNo8,617,591► SubscribeY ► Subscribe
Ucb Inc
NEUPRO
rotigotine
FILM, EXTENDED RELEASE;TRANSDERMAL021829-002May 9, 2007RXYesNo6,884,434► SubscribeY ► Subscribe
Ucb Inc
NEUPRO
rotigotine
FILM, EXTENDED RELEASE;TRANSDERMAL021829-001May 9, 2007RXYesYes8,246,979► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: rotigotine

Country Document Number Estimated Expiration
Poland376999► Subscribe
Spain2256780► Subscribe
Hungary0203318► Subscribe
Portugal1524971► Subscribe
Austria210973► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: ROTIGOTINE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/2006Austria► SubscribePRODUCT NAME: ROTIGOTINE; REGISTRATION NO/DATE: EU/1/05/331/001 - EU/1/05/331/013 20060215
C026/2006Ireland► SubscribeSPC026/2006:, EXPIRES: 20210214
269Luxembourg► Subscribe91269, EXPIRES: 20210215
C0025France► SubscribePRODUCT NAME: ROTIGOTINE; REGISTRATION NO/DATE: EU/1/05/331/001 20060215
1033978/01Switzerland► SubscribePRODUCT NAME: ROTIGOTINE; REGISTRATION NUMBER/DATE: SWISSMEDIC 57417 27.09.2006
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Mallinckrodt
Farmers Insurance
AstraZeneca
Boehringer Ingelheim
Express Scripts
UBS
Chinese Patent Office
Teva
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot